Journal
Nature Medicine
Publication Date
1-1-2023
Volume
29
Issue
1
First Page
104
Last Page
114
Document Type
Open Access Publication
DOI
10.1038/s41591-022-02128-z
Rights and Permissions
Hong, D.S., Van Tine, B.A., Biswas, S. et al. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial. Nat Med 29, 104–114 (2023). https://doi.org/10.1038/s41591-022-02128-z This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Hong, David S; Van Tine, Brian A; Ghobadi, Armin; Cashen, Amanda; and et al., "Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: A phase 1 trial." Nature Medicine. 29, 1. 104 - 114. (2023).
https://digitalcommons.wustl.edu/oa_4/1202
Additional Links
Supplemental material is available for this article at publisher site.
